![]() |
Volumn 4, Issue 4, 2003, Pages 413-417
|
Liposome formulation of NSC-639829 using halothane as a solvent: A technical note
|
Author keywords
Chloroform; Ether; Halothane; Liposome
|
Indexed keywords
2 4' AMINO 3' METHYLPHENYL BENZOTHIAZOLE;
ALCOHOL;
ANTINEOPLASTIC AGENT;
BENZOTHIAZOLE DERIVATIVE;
CHLOROFORM;
ETHER;
HALOTHANE;
LIPOSOME;
N [4 (5 BROMO 2 PYRIMIDYLOXY) 3 METHYLPHENYL](2 DIMETHYLAMINO)BENZOYLUREA;
NSC 639829;
SOLVENT;
UNCLASSIFIED DRUG;
DRUG CARRIER;
DRUG DERIVATIVE;
N 4 ((5 BROMO 2 PYRIMIDOXY) 3 METHYLPHENYL) (2 DIMETHYLAMINO)BENZOYLUREA;
N-4-((5-BROMO-2-PYRIMIDOXY)-3-METHYLPHENYL)-(2-DIMETHYLAMINO)BENZOYLUREA;
PYRIMIDINE DERIVATIVE;
UREA;
ARTICLE;
CONTROLLED STUDY;
DRUG DEGRADATION;
DRUG DELIVERY SYSTEM;
DRUG MECHANISM;
DRUG SOLUBILITY;
ENCAPSULATION;
FILM;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HYDRATION;
LIPOPHILICITY;
MICROSCOPY;
PARTICLE SIZE;
CHEMISTRY;
ANTINEOPLASTIC AGENTS;
CHEMISTRY, PHARMACEUTICAL;
DRUG CARRIERS;
DRUG DELIVERY SYSTEMS;
HALOTHANE;
LIPOSOMES;
PYRIMIDINES;
SOLVENTS;
UREA;
|
EID: 4344700369
PISSN: 15309932
EISSN: 15309932
Source Type: Journal
DOI: 10.1208/pt040452 Document Type: Article |
Times cited : (3)
|
References (12)
|